Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclaris Therapeutics, Inc. (ACRS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aclaris Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1557746.
Total stock buying since 2015: $66,563,284.
Total stock sales since 2015: $93,234,304.
Total stock option exercises since 2015: $1,217,228.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 203,333 | $0 |
| 2024 | 4,975,718 | $6,464,603 | 0 | $0 | 611,768 | $211,990 |
| 2023 | 30,695 | $225,212 | 189,238 | $2,524,988 | 345,934 | $23,543 |
| 2022 | 0 | $0 | 366,930 | $5,877,226 | 339,367 | $0 |
| 2021 | 0 | $0 | 316,879 | $7,650,833 | 551,794 | $965,611 |
| 2020 | 0 | $0 | 0 | $0 | 654,531 | $0 |
| 2019 | 0 | $0 | 1,770,150 | $7,740,797 | 45,941 | $0 |
| 2018 | 431,743 | $4,960,358 | 17,300 | $337,996 | 60,847 | $2,098 |
| 2017 | 108,601 | $2,499,995 | 1,175,000 | $34,286,250 | 24,596 | $6,715 |
| 2016 | 23,440 | $453,811 | 1,446,619 | $34,816,214 | 14,078 | $7,271 |
| 2015 | 4,653,981 | $51,959,305 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-05-05 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 15,000 | 24.16 | 362,430 |
| 2021-05-05 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 15,000 | 10.66 | 159,900 |
| 2021-05-04 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 15,000 | 24.04 | 360,555 |
| 2021-05-04 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 15,000 | 10.66 | 159,900 |
| 2021-05-03 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 15,000 | 24.68 | 370,245 |
| 2021-05-03 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 15,000 | 10.66 | 159,900 |
| 2021-04-26 | Ruffo Frank (Chief Financial Officer) | Sale | 27,339 | 26.12 | 714,012 |
| 2021-04-23 | Ruffo Frank (Chief Financial Officer) | Sale | 30,000 | 26.98 | 809,490 |
| 2021-04-22 | Ruffo Frank (Chief Financial Officer) | Sale | 30,000 | 26.84 | 805,230 |
| 2021-04-22 | Walker Neal (President and CEO) | Sale | 30,000 | 26.84 | 805,230 |
| 2021-03-02 | Gordon David N. (Chief Medical Officer) | Option Ex | 8,297 | .00 | 0 |
| 2021-03-02 | Ruffo Frank (Chief Financial Officer) | Option Ex | 8,297 | .00 | 0 |
| 2021-03-02 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 6,637 | .00 | 0 |
| 2021-03-02 | Walker Neal (President and CEO) | Option Ex | 18,253 | .00 | 0 |
| 2021-03-01 | Gordon David N. (Chief Medical Officer) | Option Ex | 20,600 | .00 | 0 |
| 2021-03-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 25,750 | .00 | 0 |
| 2021-03-01 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 17,175 | .00 | 0 |
| 2021-03-01 | Walker Neal (President and CEO) | Option Ex | 96,150 | .00 | 0 |
| 2021-02-02 | Mehra Anand (Director) | Option Ex | 14,632 | 18.34 | 268,277 |
| 2021-02-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 3,875 | .00 | 0 |
| 2021-02-01 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 3,875 | .00 | 0 |
| 2021-02-01 | Walker Neal (President and CEO) | Option Ex | 10,800 | .00 | 0 |
| 2020-12-15 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,300 | .00 | 0 |
| 2020-12-15 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,734 | .00 | 0 |
| 2020-12-15 | Walker Neal (President and CEO) | Option Ex | 3,034 | .00 | 0 |
| 2020-09-01 | Walker Neal (President and CEO) | Option Ex | 83,092 | .00 | 0 |
| 2020-07-02 | Gordon David N. (Chief Medical Officer) | Option Ex | 6,000 | .00 | 0 |
| 2020-06-06 | Humphries William D. (Director) | Option Ex | 7,333 | .00 | 0 |
| 2020-06-06 | Molineaux Christopher P. (Director) | Option Ex | 7,333 | .00 | 0 |
| 2020-06-06 | Mehra Anand (Director) | Option Ex | 7,333 | .00 | 0 |
| 2020-06-06 | Reasons Bryan M. (Director) | Option Ex | 7,333 | .00 | 0 |
| 2020-06-06 | Powell Andrew Kenneth William (Director) | Option Ex | 7,333 | .00 | 0 |
| 2020-06-06 | Schiff Andrew N (Director) | Option Ex | 7,333 | .00 | 0 |
| 2020-06-01 | Gordon David N. (Chief Medical Officer) | Option Ex | 87,500 | .00 | 0 |
| 2020-06-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 33,188 | .00 | 0 |
| 2020-06-01 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 33,188 | .00 | 0 |
| 2020-06-01 | Walker Neal (President and CEO) | Option Ex | 73,014 | .00 | 0 |
| 2020-03-02 | Gordon David N. (Chief Medical Officer) | Option Ex | 20,600 | .00 | 0 |
| 2020-03-02 | Humphries William D. (Director) | Option Ex | 8,876 | .00 | 0 |
| 2020-03-02 | Molineaux Christopher P. (Director) | Option Ex | 8,876 | .00 | 0 |
| 2020-03-02 | Ruffo Frank (Chief Financial Officer) | Option Ex | 25,750 | .00 | 0 |
| 2020-03-02 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 17,175 | .00 | 0 |
| 2020-03-02 | Walker Neal (President and CEO) | Option Ex | 148,714 | .00 | 0 |
| 2020-03-02 | Mehra Anand (Director) | Option Ex | 8,876 | .00 | 0 |
| 2020-03-02 | Reasons Bryan M. (Director) | Option Ex | 8,876 | .00 | 0 |
| 2020-03-02 | Powell Andrew Kenneth William (Director) | Option Ex | 8,876 | .00 | 0 |
| 2020-03-02 | Gowen Maxine (Director) | Option Ex | 4,438 | .00 | 0 |
| 2020-03-02 | Schiff Andrew N (Director) | Option Ex | 8,876 | .00 | 0 |
| 2020-02-03 | Ruffo Frank (Chief Financial Officer) | Option Ex | 3,875 | .00 | 0 |
| 2020-02-03 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 3,875 | .00 | 0 |
| 2020-02-03 | Walker Neal (President and CEO) | Option Ex | 10,800 | .00 | 0 |
| 2019-12-18 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2019-12-18 | Walker Neal (President and CEO) | Option Ex | 2,925 | .00 | 0 |
| 2019-12-16 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,300 | .00 | 0 |
| 2019-12-16 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,733 | .00 | 0 |
| 2019-12-16 | Walker Neal (President and CEO) | Option Ex | 3,033 | .00 | 0 |
| 2019-07-02 | Gordon David N. (Chief Medical Officer) | Option Ex | 6,000 | .00 | 0 |
| 2019-06-27 | Deerfield Partners, L.p. | Sale | 699,475 | 2.69 | 1,882,287 |
| 2019-06-26 | Deerfield Partners, L.p. | Sale | 1,704 | 4.50 | 7,671 |
| 2019-06-25 | Deerfield Partners, L.p. | Sale | 51,484 | 4.51 | 232,141 |
| 2019-06-24 | Deerfield Partners, L.p. | Sale | 63,240 | 4.52 | 286,034 |
| 2019-06-21 | Deerfield Partners, L.p. | Sale | 339,537 | 4.62 | 1,566,963 |
| 2019-05-10 | Deerfield Partners, L.p. | Sale | 180,565 | 6.05 | 1,092,237 |
| 2019-05-09 | Deerfield Partners, L.p. | Sale | 434,145 | 6.16 | 2,673,464 |
| 2019-02-01 | Fair Brett (Chief Commercial Officer) | Option Ex | 3,875 | .00 | 0 |
| 2019-02-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 3,875 | .00 | 0 |
| 2019-02-01 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 3,875 | .00 | 0 |
| 2019-02-01 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 3,875 | .00 | 0 |
| 2019-02-01 | Powala Christopher (Chief Reg & Develop Officer) | Option Ex | 3,400 | .00 | 0 |
| 2019-02-01 | Walker Neal (President and CEO) | Option Ex | 10,800 | .00 | 0 |
| 2018-12-18 | Fair Brett (Chief Commercial Officer) | Option Ex | 1,750 | .00 | 0 |
| 2018-12-18 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2018-12-18 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,075 | .00 | 0 |
| 2018-12-18 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 1,450 | .00 | 0 |
| 2018-12-18 | Powala Christopher (Chief Reg & Develop Officer) | Option Ex | 1,625 | .00 | 0 |
| 2018-12-18 | Walker Neal (President and CEO) | Option Ex | 2,925 | .00 | 0 |
| 2018-12-15 | Fair Brett (Chief Commercial Officer) | Option Ex | 1,013 | .00 | 0 |
| 2018-12-15 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,300 | .00 | 0 |
| 2018-12-15 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,733 | .00 | 0 |
| 2018-12-15 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 1,300 | .00 | 0 |
| 2018-12-15 | Powala Christopher (Chief Reg & Develop Officer) | Option Ex | 1,300 | .00 | 0 |
| 2018-12-15 | Walker Neal (President and CEO) | Option Ex | 3,033 | .00 | 0 |
| 2018-10-22 | Mehra Anand | Buy | 372,093 | 10.75 | 3,999,999 |
| 2018-10-04 | Tullman Stephen A. (Director) | Buy | 7,100 | 14.00 | 99,371 |
| 2018-08-23 | Tullman Stephen A. (Director) | Buy | 6,600 | 15.00 | 98,986 |
| 2018-08-15 | Tullman Stephen A. (Director) | Buy | 6,250 | 15.97 | 99,812 |
| 2018-06-12 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 4,900 | 20.00 | 98,000 |
| 2018-06-11 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 100 | 20.00 | 2,000 |
| 2018-05-18 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 10,000 | 20.00 | 200,000 |
| 2018-05-16 | Powell Andrew Kenneth William (Director) | Buy | 500 | 19.12 | 9,560 |
| 2018-05-07 | Fair Brett (Chief Commercial Officer) | Option Ex | 4,050 | .00 | 0 |
| 2018-05-07 | Ruffo Frank (Chief Financial Officer) | Buy | 1,250 | 18.22 | 22,775 |
| 2018-05-07 | Ruffo Frank (Chief Financial Officer) | Option Ex | 5,200 | .00 | 0 |
| 2018-05-07 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 6,933 | .00 | 0 |
| 2018-05-07 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 5,200 | .00 | 0 |
| 2018-05-07 | Powala Christopher (Chief Reg & Develop Officer) | Option Ex | 5,200 | .00 | 0 |
| 2018-05-07 | Walker Neal (President and CEO) | Option Ex | 12,133 | .00 | 0 |
| 2018-04-06 | Molineaux Christopher P. (Director) | Sale | 2,300 | 16.52 | 37,996 |
| 2018-04-06 | Ruffo Frank (Chief Financial Officer) | Buy | 1,250 | 16.59 | 20,737 |
| 2018-04-06 | Tullman Stephen A. (Director) | Buy | 26,700 | 16.54 | 441,618 |
| 2018-04-05 | Walker Neal (President and CEO) | Buy | 10,000 | 16.75 | 167,500 |
| 2018-03-20 | Molineaux Christopher P. (Director) | Option Ex | 2,377 | .88 | 2,098 |
| 2017-12-18 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2017-12-18 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,075 | .00 | 0 |
| 2017-12-18 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 1,450 | .00 | 0 |
| 2017-12-18 | Powala Christopher (Chief Operating Officer) | Option Ex | 1,625 | .00 | 0 |
| 2017-12-18 | Walker Neal (President and CEO) | Option Ex | 2,925 | .00 | 0 |
| 2017-12-15 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,300 | .00 | 0 |
| 2017-12-15 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,733 | .00 | 0 |
| 2017-12-15 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 1,300 | .00 | 0 |
| 2017-12-15 | Powala Christopher (Chief Operating Officer) | Option Ex | 1,300 | .00 | 0 |
| 2017-12-15 | Walker Neal (President and CEO) | Option Ex | 3,033 | .00 | 0 |
| 2017-08-16 | Schiff Andrew N (Director) | Buy | 108,601 | 23.02 | 2,499,995 |
| 2017-03-17 | Molineaux Christopher P. (Director) | Option Ex | 7,605 | .88 | 6,715 |
| 2017-03-02 | Vivo Ventures Vii Affiliates Fund, L.p. | Sale | 125,000 | 31.20 | 3,900,000 |
| 2017-03-01 | Vivo Ventures Vii Affiliates Fund, L.p. | Sale | 100,000 | 30.98 | 3,098,000 |
| 2017-02-28 | Vivo Ventures Vii Affiliates Fund, L.p. | Sale | 200,000 | 30.50 | 6,100,000 |
| 2017-01-10 | Mehra Anand | Sale | 750,000 | 28.25 | 21,188,250 |
| 2016-12-18 | Ruffo Frank (Chief Financial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2016-12-18 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,075 | .00 | 0 |
| 2016-12-18 | Shanler Stuart (Chief Scientific Officer) | Option Ex | 1,450 | .00 | 0 |
| 2016-12-18 | Powala Christopher (Chief Operating Officer) | Option Ex | 1,625 | .00 | 0 |
| 2016-12-18 | Walker Neal (President and CEO) | Option Ex | 2,925 | .00 | 0 |
| 2016-11-18 | Vivo Ventures Vii Affiliates Fund, L.p. | Sale | 450,000 | 22.72 | 10,224,000 |
| 2016-11-16 | Vivo Ventures Vii Affiliates Fund, L.p. | Sale | 457,828 | 25.27 | 11,571,602 |
| 2016-10-26 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 3,912 | 21.83 | 85,398 |
| 2016-10-26 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 3,912 | 1.52 | 5,946 |
| 2016-10-26 | Fmr Llc (Other) | Sale | 3,750 | 22.04 | 82,650 |
| 2016-09-28 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 1,841 | 24.66 | 45,399 |
| 2016-09-28 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 1,841 | .72 | 1,325 |
| 2016-09-16 | Ra Capital Healthcare Fund Lp | Sale | 173,600 | 24.52 | 4,256,845 |
| 2016-09-15 | Ra Capital Healthcare Fund Lp | Sale | 351,950 | 24.08 | 8,474,252 |
| 2016-08-26 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 3,738 | 20.35 | 76,068 |
| 2016-01-20 | Ra Capital Healthcare Fund Lp | Buy | 1,803 | 19.88 | 35,849 |
| 2016-01-19 | Ra Capital Healthcare Fund Lp | Buy | 4,200 | 19.88 | 83,479 |
| 2016-01-15 | Ra Capital Healthcare Fund Lp | Buy | 1,800 | 19.86 | 35,742 |
| 2016-01-13 | Ra Capital Healthcare Fund Lp | Buy | 5,543 | 19.97 | 110,677 |
| 2016-01-12 | Ra Capital Healthcare Fund Lp | Buy | 5,941 | 19.12 | 113,585 |
| 2016-01-11 | Ra Capital Healthcare Fund Lp | Buy | 4,153 | 17.93 | 74,479 |
| 2015-10-29 | Ra Capital Healthcare Fund Lp | Buy | 95,000 | 14.00 | 1,330,000 |
| 2015-10-28 | Ra Capital Healthcare Fund Lp | Buy | 149,200 | 14.00 | 2,088,800 |
| 2015-10-22 | Ra Capital Healthcare Fund Lp | Buy | 5,410 | 14.03 | 75,880 |
| 2015-10-21 | Kolchinsky Peter | Buy | 3,100 | 14.83 | 45,976 |
| 2015-10-20 | Kolchinsky Peter | Buy | 7,965 | 14.95 | 119,068 |
| 2015-10-19 | Kolchinsky Peter | Buy | 23,934 | 14.88 | 356,042 |
| 2015-10-14 | Kolchinsky Peter | Buy | 42,813 | 14.06 | 601,779 |
| 2015-10-13 | Mehra Anand (Director) | Buy | 409,090 | 11.00 | 4,499,990 |
| 2015-10-13 | Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) | Buy | 454,545 | 11.00 | 4,999,995 |
| 2015-10-13 | Cha Albert (Director) | Buy | 454,545 | 11.00 | 4,999,995 |
| 2015-10-13 | Powell Michael (10% Owner) | Buy | 409,090 | 11.00 | 4,499,990 |
| 2015-10-13 | Fmr Llc (Other) | Buy | 335,455 | 11.00 | 3,690,005 |
| 2015-10-08 | Kolchinsky Peter | Buy | 21,691 | 11.00 | 238,557 |
| 2015-10-07 | Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) | Buy | 13,352 | 11.00 | 146,872 |
| 2015-10-07 | Cha Albert (Director) | Buy | 13,352 | 11.00 | 146,872 |
| 2015-10-07 | Kolchinsky Peter | Buy | 2,215,439 | 10.89 | 24,119,484 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACRS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aclaris Therapeutics, Inc. (symbol ACRS, CIK number 1557746) see the Securities and Exchange Commission (SEC) website.